| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/12/2001 | WO2001025426A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 04/12/2001 | WO2001025425A1 NUCLEAR LOCALIZED RecQ5 TYPE DNA HELICASE |
| 04/12/2001 | WO2001025424A1 Recombinant antigen of taenia solium metacestodes |
| 04/12/2001 | WO2001025423A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | WO2001025422A2 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | WO2001025421A2 Materials and method for detecting interaction of cftr polypeptides |
| 04/12/2001 | WO2001025420A2 Adjustable sensitivity, genetic molecular interaction systems, including protein-protein interaction systems for detection and analysis |
| 04/12/2001 | WO2001025419A1 ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO |
| 04/12/2001 | WO2001025418A1 SELECTIVE ISOLATION OF BACTERIAL mRNA |
| 04/12/2001 | WO2001025417A2 Dna library and its use in methods of selecting and designing polypeptides |
| 04/12/2001 | WO2001025416A1 Recombinant double hybrid filamentous bacteriophage |
| 04/12/2001 | WO2001025415A2 Gene transfer in human lymphocytes using retroviral scfv cell targeting |
| 04/12/2001 | WO2001025408A1 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 04/12/2001 | WO2001025405A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | WO2001025401A2 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 04/12/2001 | WO2001025398A2 Process for inducing functional tolerance to gene transfer products |
| 04/12/2001 | WO2001025397A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | WO2001025282A1 Il13 mutants |
| 04/12/2001 | WO2001025279A1 Cd29 pig protein, nucleic acid coding for said protein and the applications thereof |
| 04/12/2001 | WO2001025278A1 C-peptide for the improved production of insulin and insulin analogues |
| 04/12/2001 | WO2001025274A1 Mitofusins, fzo homologs and functional derivatives thereof |
| 04/12/2001 | WO2001025271A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025268A1 Human seizure related proteins |
| 04/12/2001 | WO2001025258A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | WO2001025253A2 Temperature-sensitive regulation of viral vector production |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025249A1 Compositions and methods for identifying polypeptides and nucleic acid molecules |
| 04/12/2001 | WO2001025248A2 Design of high affinity rnase h recruiting oligonucleotide |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001024937A2 Separation apparatus and method |
| 04/12/2001 | WO2001024929A1 Substrate with at least one pore |
| 04/12/2001 | WO2001024820A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024811A1 April receptor (bcma) and uses thereof |
| 04/12/2001 | WO2001024810A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | WO2001024781A2 Gene necessary for striatal function, uses thereof, and compounds for modulating same |
| 04/12/2001 | WO2001024773A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001024684A2 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | WO2001024681A2 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 04/12/2001 | WO2001024628A1 Model animal of mesangial cell proliferative nephritis |
| 04/12/2001 | WO2001024627A1 Animal with the mass expression of human gene and test method by using the animal |
| 04/12/2001 | WO2001024626A1 Prevention and treatment of diseases associated with blood coagulation |
| 04/12/2001 | WO2001024625A1 Transgenic rodent comprising a polynucleotide emcoding a human ucp3 polynucleotide |
| 04/12/2001 | WO2001024624A2 Method for reconstructing a non-human mammal embryo with foetal adult differentiated cells |
| 04/12/2001 | WO2001024616A1 Method of constructing male sterile plant |
| 04/12/2001 | WO2001024615A1 Non-transgenic herbicide resistant plants |
| 04/12/2001 | WO2000077190A3 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 04/12/2001 | WO2000074723A3 Methods for the gene therapy of benign prostatic hyperplasia and medical agents therefore |
| 04/12/2001 | WO2000073328A3 Unc-5 constructs and screening methods |
| 04/12/2001 | WO2000069454A8 Suppression of endogenous igfbp-2 to inhibit cancer |
| 04/12/2001 | WO2000068406A3 Disease resistance factors |
| 04/12/2001 | WO2000066762A3 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 04/12/2001 | WO2000065063A3 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 04/12/2001 | WO2000065055A3 Human transporter proteins |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO2000061735A8 Modification of plant storage reserves |
| 04/12/2001 | WO2000061615A3 Homologs of mar-binding filament-like protein 1 (mfp1) |
| 04/12/2001 | WO2000060058A3 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 04/12/2001 | WO2000059297A3 Methods for tracking the progression of alzheimer's disease and identifying treatments using transgenic mice |
| 04/12/2001 | WO2000049166A3 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 04/12/2001 | WO2000049031A3 Method for isolating nucleic acids |
| 04/12/2001 | WO2000046406A3 Arrays for investigating protein protein interactions |
| 04/12/2001 | WO2000040736A3 Molecular-biological marker for analytical electron microscopy |
| 04/12/2001 | WO2000039289A3 Endo-beta-1,4-xylanase inhibitor aus weizenmehl und seine wirkung auf verschiedene xylanasen |
| 04/12/2001 | WO2000036087A9 Nucleolus autoantigenic marker for systematic lupus erythematosus |
| 04/12/2001 | WO2000031241A3 Polypeptides having choline oxidase activity and nucleic acids encoding same |
| 04/12/2001 | WO2000026667A9 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 04/12/2001 | WO2000018881A8 Intein mediated peptide ligation |
| 04/12/2001 | WO2000012123A3 Method and measuring device for determining a plurality of analytes in a sample |
| 04/12/2001 | WO2000006199A8 Kvlqt1 - a long qt syndrome gene |
| 04/12/2001 | WO2000000616A9 Marburg virus vaccines |
| 04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 04/12/2001 | WO1999051735A3 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy |
| 04/12/2001 | WO1998016632B1 MATERIALS AND METHODS FOR DETECTION OF $i(OXALOBACTER) |
| 04/12/2001 | WO1997020056A3 Enhancer-increased gene expression in plants |
| 04/12/2001 | WO1997011189A3 Plant glutathione s-transferase promoters |
| 04/12/2001 | WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/12/2001 | US20010000266 Recombinant DNA molecule comprising promoter linked to sequence encoding polypeptide comprising chloroplast transit peptide linked to NADP-GDH polypeptide, said sequence encoding polypeptide linked to transcriptional termination region |
| 04/12/2001 | US20010000228 Use of a modified baculovirus containing exogenous nucleic acid for the manufacture of a medicament for delivering said nucleic acid to the hepatocytes |
| 04/12/2001 | DE19949000A1 PRPP-Amidotransferase aus Pflanzen PRPP amidotransferase from plants |
| 04/12/2001 | DE19947792A1 Neue für das Irp Gen codierende Nukleotidsequenzen New gene nucleotide sequences coding for the Irp |
| 04/12/2001 | DE19947791A1 Neue für das eno-Gen codierende Nukleotidsequenzen New coding for the eno gene nucleotide sequences |
| 04/12/2001 | CA2389441A1 Compositions and methods for plant genetic modification |
| 04/12/2001 | CA2389282A1 Cloning vectors |
| 04/12/2001 | CA2388533A1 Utrophin gene promoter |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2388408A1 Prevention and treatment of diseases associated with blood coagulation |
| 04/12/2001 | CA2388227A1 A human gene over-expressing animal and test methods using the animal |
| 04/12/2001 | CA2386854A1 Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins |
| 04/12/2001 | CA2386841A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | CA2386834A1 Non-transgenic herbicide resistant plants |
| 04/12/2001 | CA2386820A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 04/12/2001 | CA2386722A1 Materials and methods for simplified aav production |
| 04/12/2001 | CA2386546A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386533A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules |